Dialysis-induced myocardial stunning: the other side of the cardiorenal syndrome.
暂无分享,去创建一个
[1] C. McIntyre,et al. Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning). , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[2] C. McIntyre,et al. Individualised Dialysate Temperature Improves Intradialytic Haemodynamics and Abrogates Haemodialysis-Induced Myocardial Stunning, without Compromising Tolerability , 2011, Blood Purification.
[3] M. Woodward,et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.
[4] S. Solomon,et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. , 2009, The New England journal of medicine.
[5] E. Ritz,et al. Cardiovascular problems on hemodialysis: current deficits and potential improvement. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[6] N. Selby,et al. Hemodialysis-induced cardiac injury: determinants and associated outcomes. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[7] John G F Cleland,et al. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. , 2007, Journal of cardiac failure.
[8] E. Ritz,et al. Dialysis, cardiovascular disease, and the future , 2007 .
[9] Huiman Barnhart,et al. Correction of anemia with epoetin alfa in chronic kidney disease. , 2006, The New England journal of medicine.
[10] P. Schirmacher,et al. Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[11] N. Selby,et al. Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[12] F. Zannad,et al. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. , 2006, Kidney international.
[13] Harlan M Krumholz,et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. , 2006, Journal of the American College of Cardiology.
[14] N. Selby,et al. Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] C. McIntyre,et al. Vascular calcification and cardiovascular function in chronic kidney disease. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[16] J. Keyser,et al. Myocardial calcification: a rare cause of diastolic dysfunction , 2006, Heart.
[17] C. Herzog. Sudden cardiac death and acute myocardial infarction in dialysis patients: perspectives of a cardiologist. , 2005, Seminars in nephrology.
[18] W. März,et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. , 2005, The New England journal of medicine.
[19] V. Jha,et al. Silent Myocardial Ischemia and High-Grade Ventricular Arrhythmias in Patients on Maintenance Hemodialysis , 2005, Renal failure.
[20] H. Samady,et al. Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries. , 2004, American heart journal.
[21] G. London,et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[22] C. Herzog. Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome. , 2003, Kidney international. Supplement.
[23] N. Powe,et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. , 2002, Journal of the American Society of Nephrology : JASN.
[24] Sharon M Moe,et al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. , 2002, Kidney international.
[25] J. Blacher,et al. Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease , 2001, Hypertension.
[26] M. Caty,et al. Intestinal and hemodynamic impairment following mesenteric ischemia/reperfusion. , 2001, The Journal of surgical research.
[27] R. Elashoff,et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. , 2000, The New England journal of medicine.
[28] N. Westerhof,et al. Cardiac and hemodynamic effects of hemodialysis and ultrafiltration. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[29] J E Parrillo,et al. Myocardial dysfunction in septic shock. , 2000, Critical care clinics.
[30] E. Ritz,et al. Myocyte/capillary mismatch in the heart of uremic patients. , 1998, Journal of the American Society of Nephrology : JASN.
[31] J. Daugirdas,et al. Splanchnic erythrocyte content decreases during hemodialysis: a new compensatory mechanism for hypovolemia. , 1997, Kidney international.
[32] Y. Sugishita,et al. Chronically decreased aortic distensibility causes deterioration of coronary perfusion during increased left ventricular contraction. , 1994, Journal of the American College of Cardiology.
[33] E. Braunwald,et al. The Stunned Myocardium: Prolonged, Postischemic Ventricular Dysfunction , 1982, Circulation.
[34] P. Li,et al. Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[35] P. Ponikowski,et al. Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). , 2010, Contributions to nephrology.
[36] N. Selby,et al. Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[37] A. Langer,et al. Myocardial alterations during hemodialysis: insights from new noninvasive technology. , 1994, American journal of nephrology.
[38] R. Wilson,et al. Gastric intramucosal acidosis in patients with chronic kidney failure. , 1993, Surgery.
[39] R. Ritz,et al. Incidence of arrhythmias and myocardial ischaemia during haemodialysis and haemofiltration. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.